A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives
About 1 in 6 Americans report paying more than 10 percent of their total family income for health insurance premiums, says the latest report from the Agency for Healthcare Research and Quality. Of those with employer-sponsored insurance, 16 percent spend 10 percent or more of their income on premiums and out-of-pocket expenses. Of those with public insurance, 16 percent spend 10 percent or more of their income on out-of-pocket expenses (and 84 percent do not).… Advising adult patients to get vaccinated for the flu, especially during the 2009–2010 pandemic, would seem to make a lot of sense. But a study in Preventive Medicine suggests that 64 percent of adults did not receive any provider-issued influenza vaccination recommendation. Adults who were advised to get vaccinated were 14.1 to 32.1 percentage points more likely to get vaccinated than adults who did not receive a recommendation…. A merger between Medco and Sanofi will help the French drug manufacturer navigate the American payer and regulatory landscape. Sanofi’s research and development will benefit from the merger, gaining a perspective on the views of health insurers and governments that are seeking evidence of a drug’s demonstrated benefits before paying for it. Sanofi will benefit from Medco’s voluminous claims data, which it collects by providing pharmacy benefits to millions. Medco will be a consultant to the drugmaker on comparative studies for both experimental and approved drugs.
Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report